These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16272751)

  • 21. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
    Mio Y
    Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective Dose of Landiolol, an Ultra-Short-Acting β-Blocker, to Decrease Heart Rate During On-Pump, Beating Coronary Artery Bypass Grafting.
    Kawashima S; Kurita T; Morita K; Nakajima Y
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2195-2200. PubMed ID: 30902552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Landiolol Hydrochloride Rapidly Controls Junctional Ectopic Tachycardia After Pediatric Heart Surgery.
    Yoneyama F; Tokunaga C; Kato H; Nakajima T; Mathis BJ; Sakamoto H; Hiramatsu Y
    Pediatr Crit Care Med; 2018 Aug; 19(8):713-717. PubMed ID: 29677032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of landiolol on hemodynamic response and seizure duration during electroconvulsive therapy.
    Nomoto K; Suzuki T; Serada K; Oe K; Yoshida T; Yamada S
    J Anesth; 2006; 20(3):183-7. PubMed ID: 16897237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of a bolus injection of landiolol hydrochloride as a premedication for multidetector-row computed tomography coronary angiography.
    Osawa K; Miyoshi T; Sato S; Akagi N; Morimitsu Y; Nakamura K; Kohno K; Kusano K; Kanazawa S; Ito H
    Circ J; 2013; 77(1):146-52. PubMed ID: 23037522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Landiolol, an ultra short-acting beta1-adrenoceptor antagonist, does not alter the minimum alveolar anesthetic concentration of isoflurane in a swine model.
    Kurita T; Takata K; Uraoka M; Morita K; Sato S
    Anesth Analg; 2007 Sep; 105(3):656-60. PubMed ID: 17717219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Landiolol infusion attenuates increase in heart rate, but does not prevent increase in blood pressure in response to emergence from anesthesia and tracheal extubation].
    Horiuchi T; Uchida S; Kadoi Y; Saito S; Sasaki M; Yoshikawa D; Sugaya T; Shimada H; Maruyama N; Satoh J; Nara T; Takahashi K
    Masui; 2010 Sep; 59(9):1178-84. PubMed ID: 20857678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients.
    Taenaka N; Kikawa S
    Clin Drug Investig; 2013 Jul; 33(7):505-14. PubMed ID: 23728899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs.
    Takahashi S; Fujii Y; Hoshi T; Inomata S; Miyabe M; Toyooka H
    Can J Anaesth; 2000 Mar; 47(3):265-72. PubMed ID: 10730740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
    Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
    J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy.
    Hirota K; Baba S; Fukushi S; Muraoka M; Matsuki A
    J Anesth; 2005; 19(1):17-20. PubMed ID: 15674510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.
    Sasao J; Tarver SD; Kindscher JD; Taneyama C; Benson KT; Goto H
    Can J Anaesth; 2001 Nov; 48(10):985-9. PubMed ID: 11698317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of landiolol on cardiovascular responses, bispectral index and body movement during endotracheal intubation].
    Kawano T; Eguchi S; Iseki A; Oshita S
    Masui; 2005 Jun; 54(6):610-4. PubMed ID: 15966376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
    Hoshi T; Sato A; Nishina H; Kakefuda Y; Wang Z; Noguchi Y; Aonuma K
    J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
    Kobayashi S; Murakami W; Myoren T; Tateishi H; Okuda S; Doi M; Nao T; Wada Y; Matsuzaki M; Yano M
    Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
    Adachi T; Sato A; Baba M; Hiraya D; Hasegawa T; Kuroki K; Hoshi T; Aonuma K
    Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous administration of landiolol reduced QT dispersion in postoperative patients.
    Suzuki K; Numaguchi A; Adachi YU; Obata Y; Hatano T; Ejima T; Sato S; Matsuda N
    J Clin Anesth; 2014 Sep; 26(6):438-42. PubMed ID: 25204509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.
    Miwa Y; Ikeda T; Mera H; Miyakoshi M; Hoshida K; Yanagisawa R; Ishiguro H; Tsukada T; Abe A; Yusu S; Yoshino H
    Circ J; 2010 May; 74(5):856-63. PubMed ID: 20339194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of landiolol, a short-acting beta-1 blocker, on hemodynamic variables during emergence from anesthesia and tracheal extubation in elderly patients with and without hypertension.
    Miyazaki M; Kadoi Y; Saito S
    J Anesth; 2009; 23(4):483-8. PubMed ID: 19921354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.